Myasthenia Gravis, Generalized research hub
3 indexed studies · 0 currently recruiting
- active not recruitingPHASE2
A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC)
This study is testing a new medicine, Claseprubart (also called DNTH103), for adults with a condition called generalized myasthenia gravis (gMG). We want to see if the medicine is safe, well-tolerated, and helps improve symptoms. Some people will get the new medicine, and others a placebo.
United States · Argentina · Canada - active not recruitingPHASE2
Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)
This study is looking at a new treatment called Descartes-08 CAR T-cells for people with a muscle weakness condition called Generalized Myasthenia Gravis. It's in an early stage (Phase IIb) to check if the treatment is safe and if it helps people feel better.
United States · Canada - active not recruitingPHASE3
A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis
This study is testing a new medicine called efgartigimod for people with a type of Myasthenia Gravis (MG). It checks how well it works and if it's safe compared to a dummy medicine. Some people will then get the new medicine openly.
United States · Belgium · Canada